Business

4DMT to Participate in Upcoming Investor Conferences

EMERYVILLE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will participate in fireside chats at upcoming investor conferences in September. Members of the management team will also be available for one-on-one meetings.

article4d Molecular Therapeutics, Inc.August 25, 20252/company/4d-molecular-therapeutics-inc/news/4dmt-participate-upcoming-investor-conferences-120000763
4DMT to Participate in Upcoming Investor Conferences

About this update from 4d Molecular Therapeutics, Inc.

[{"type":"image","alt":"4D Molecular Therapeutics, Inc.","displaySize":"","headline":null,"caption":"4D Molecular Therapeutics, Inc.","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":85,"url":"https://media.zenfs.com/en/globenewswire.com/77c43650e1f3f7dcc5fea422c8ad89a8"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/OBgOYDeK6BG2g1ABskfhkQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTExOTtjZj13ZWJw/https://media.zenfs.com/en/globenewswire.com/77c43650e1f3f7dcc5fea422c8ad89a8","width":300,"height":85}},"lazy":false},{"type":"text","content":"EMERYVILLE, Calif., Aug. 25, 2025 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients, today announced that management will participate in fireside chats at upcoming investor conferences in September. Members of the management team will also be available for one-on-one meetings.","length":505,"tagName":"p"},{"type":"text","content":"Cantor Global Healthcare Conference 2025","length":40,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"max-width:30%;width:30%;min-width:30%;vertical-align:top;","val":[{"type":"text","content":"Presentation Date:","length":18,"tagName":"p","attribs":{}}]},{"style":"max-width:70%;width:70%;min-width:70%;vertical-align:middle;text-align:left;padding-left:10.0px;vertical-align:top;","val":[{"type":"text","content":"Thursday, Sept 4, 2025","length":22,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":"Presentation Time:","length":18,"tagName":"p","attribs":{}}]},{"style":"vertical-align:middle;text-align:left;padding-left:10.0px;vertical-align:top;","val":[{"type":"text","content":"11:30 a.m. ET","length":13,"tagName":"p","attribs":{}}]}]},{"val":[{"style":"vertical-align:top;","val":[{"type":"text","content":"Webcast Link:","length":13,"tagName":"p","attribs":{}}]},{"style":"vertical-align:middle;text-align:left;padding-left:10.0px;vertical-align:top;","val":[{"type":"text","content":"Webcast","length":7,"tagName":"p","attribs":{}}]}]}],"length":91},{"type":"text","content":"H.C. Wainwright 27th Annual Global Investment Conference","length":56,"tagName":"p"},{"t...

More updates from 4d Molecular Therapeutics, Inc.

biotechnology companyunprecedented benefitsGlobal Healthcare ConferenceCompanyWebcast LinkThe Company